374538-23-5
|
|
- CAS号:
- 374538-23-5
- 英文名:
- 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-
- 英文别名:
- Neuromuscular Disorder-Targeting Compound 1;1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-
- 中文名:
- 374538-23-5
- 中文别名:
- NEUROMUSCULAR DISORDER-TARGETING COMPOUND 1
- CBNumber:
- CB33339555
- 分子式:
- C15H25N3S
- 分子量:
- 279.44
- MOL File:
- 374538-23-5.mol
|
|
|
374538-23-5化学性质
-
沸点:
-
452.3±40.0 °C(Predicted)
-
|
-
密度:
-
1.089±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
15.32±0.40(Predicted)
-
|
374538-23-5性质、用途与生产工艺
Neuromuscular Disorder-Targeting Compound 1 可用于研究神经肌肉紊乱症,例如肌痛综合征和慢性疲劳综合症。
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
374538-23-5
上下游产品信息
上游原料
下游产品
374538-23-5, 374538-23-5 相关搜索:
- NEUROMUSCULAR DISORDER-TARGETING COMPOUND 1
- 374538-23-5
- Neuromuscular Disorder-Targeting Compound 1
- 1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel-